scholarly article | Q13442814 |
P50 | author | Hong Jiang | Q87811127 |
P2093 | author name string | Hao Wang | |
Rong Hu | |||
Yu Sun | |||
Chen Huang | |||
Jia Yan | |||
Yelin Chen | |||
Chunzhu Li | |||
Dewei Tang | |||
Chaoying Fu | |||
Jidong Zhu | |||
P2860 | cites work | Ketamine activates cell cycle signaling and apoptosis in the neonatal rat brain. | Q43085996 |
The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine | Q44337930 | ||
The Role of Science in Addressing the Opioid Crisis | Q44346078 | ||
Nalmefene: safety and kinetics after single and multiple oral doses of a new opioid antagonist | Q44350017 | ||
The fentanyl story | Q46163348 | ||
Nalmefene reverses carfentanil-induced loss of righting reflex and respiratory depression in rats | Q47863006 | ||
Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits | Q48569969 | ||
Maximum tolerated dose of nalmefene in patients receiving epidural fentanyl and dilute bupivacaine for postoperative analgesia. | Q51368362 | ||
Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery. | Q51373415 | ||
Sevoflurane induces neurotoxicity in the developing rat hippocampus by upregulating connexin 43 via the JNK/c-Jun/AP-1 pathway | Q58123276 | ||
Safety and Efficacy of Ketamine Versus Ketamine-Fentanyl-Dexmedetomidine Combination for Anesthesia and Analgesia in Rats | Q64245398 | ||
Neurosteroids and glutamate toxicity in fibroblasts expressing human NMDA receptors | Q73581332 | ||
Ketamine | Q81443501 | ||
Ketamine-induced hypnosis and neuroplasticity in mice is associated with disrupted p-MEK/p-ERK sequential activation and sustained upregulation of survival p-FADD in brain cortex: Involvement of GABAA receptor | Q90024191 | ||
Flumazenil but not bicuculline counteract the impairing effects of anesthetic ketamine on recognition memory in rats. Evidence for a functional interaction between the GABAA-benzodiazepine receptor and ketamine? | Q90825276 | ||
Sirtuin 2 Inhibition Attenuates Sevoflurane-Induced Learning and Memory Deficits in Developing Rats via Modulating Microglial Activation | Q91240593 | ||
17β-Estradiol Treatment Attenuates Neurogenesis Damage and Improves Behavior Performance After Ketamine Exposure in Neonatal Rats | Q91531522 | ||
Metabotropic functions of the NMDA receptor and an evolving rationale for exploring NR2A-selective positive allosteric modulators for the treatment of autism spectrum disorder | Q93341615 | ||
Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function | Q27704016 | ||
Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design | Q27704191 | ||
The effects of increasing plasma concentrations of dexmedetomidine in humans | Q28141747 | ||
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors | Q28570615 | ||
Ketamine alters cortical integration of GABAergic interneurons and induces long-term sex-dependent impairments in transgenic Gad67-GFP mice | Q30585962 | ||
Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing | Q33987817 | ||
D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis | Q34006224 | ||
Clinical uses of alpha2 -adrenergic agonists | Q34068639 | ||
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery | Q34139176 | ||
Anesthetics and ion channels: molecular models and sites of action | Q34192657 | ||
Recovery from ketamine-induced amnesia by blockade of GABA-A receptor in the medial prefrontal cortex of mice | Q34516988 | ||
Diversity in NMDA receptor composition: many regulators, many consequences | Q36597018 | ||
Ketamine enhances human neural stem cell proliferation and induces neuronal apoptosis via reactive oxygen species-mediated mitochondrial pathway | Q36711438 | ||
Intravenous vs intramuscular ketamine for pediatric procedural sedation by emergency medicine specialists: a review | Q37780565 | ||
Dexmedetomidine sedation: uses in pediatric procedural sedation outside the operating room | Q37990758 | ||
A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer | Q38436582 | ||
Efficacy of intraoperative dexmedetomidine compared with placebo for surgery in adults: a meta-analysis of published studies | Q38501031 | ||
Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy | Q39008536 | ||
Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators | Q39121207 | ||
Fatal Fentanyl: One Pill Can Kill | Q39670532 | ||
Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors | Q41082995 | ||
In vivo studies identify 5 alpha-pregnan-3 alpha-ol-20-one as an active anesthetic agent | Q41161435 | ||
GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile | Q41792375 | ||
Nalmefene: intravenous safety and kinetics of a new opioid antagonist | Q42226511 | ||
Nalmefene is effective at reducing alcohol seeking, treating alcohol-cocaine interactions and reducing alcohol-induced histone deacetylases gene expression in blood. | Q42406039 | ||
P433 | issue | 1 | |
P304 | page(s) | 5265 | |
P577 | publication date | 2020-03-24 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | GluN2A-selective positive allosteric modulator-nalmefene-flumazenil reverses ketamine-fentanyl-dexmedetomidine-induced anesthesia and analgesia in rats | |
P478 | volume | 10 |
Search more.